癌症疼痛管理药学专家共识

2019-11-30 北京市疼痛治疗质量控制和改进中心癌痛专家组 中国疼痛医学杂志.2019, 25(11):801-807.

癌痛发病机制复杂,临床表现多样,治疗效果的影响因素众多,组建多学科疼痛管理团队已成为广泛共识。药学部门在癌痛治疗药物规范使用与管理中占有非常重要的地位,其工作内容涉及药事管理和药学服务中的各个环节。为充分发挥药学专业技术人员在癌痛药物治疗过程中的作用,结合我国癌痛治疗现状,特制定本共识,以期为推进癌痛规范化管理的药学服务实践提供指引。

中文标题:

癌症疼痛管理药学专家共识

发布日期:

2019-11-30

简要介绍:

癌痛发病机制复杂,临床表现多样,治疗效果的影响因素众多,组建多学科疼痛管理团队已成为广泛共识。药学部门在癌痛治疗药物规范使用与管理中占有非常重要的地位,其工作内容涉及药事管理和药学服务中的各个环节。为充分发挥药学专业技术人员在癌痛药物治疗过程中的作用,结合我国癌痛治疗现状,特制定本共识,以期为推进癌痛规范化管理的药学服务实践提供指引。

 

拓展指南:癌症相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=癌症疼痛管理药学专家共识)] GetToolGuiderByIdResponse(projectId=1, id=0a0451c001839214, title=癌症疼痛管理药学专家共识, enTitle=, guiderFrom=中国疼痛医学杂志.2019, 25(11):801-807., authorId=null, author=, summary=癌痛发病机制复杂,临床表现多样,治疗效果的影响因素众多,组建多学科疼痛管理团队已成为广泛共识。药学部门在癌痛治疗药物规范使用与管理中占有非常重要的地位,其工作内容涉及药事管理和药学服务中的各个环节。为充分发挥药学专业技术人员在癌痛药物治疗过程中的作用,结合我国癌痛治疗现状,特制定本共识,以期为推进癌痛规范化管理的药学服务实践提供指引。 , cover=, journalId=null, articlesId=null, associationId=1573, associationName=北京市疼痛治疗质量控制和改进中心癌痛专家组, associationIntro=, copyright=0, guiderPublishedTime=Sat Nov 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>癌痛发病机制复杂,临床表现多样,治疗效果的影响因素众多,组建多学科疼痛管理团队已成为广泛共识。药学部门在癌痛治疗药物规范使用与管理中占有非常重要的地位,其工作内容涉及药事管理和药学服务中的各个环节。为充分发挥药学专业技术人员在癌痛药物治疗过程中的作用,结合我国癌痛治疗现状,特制定本共识,以期为推进癌痛规范化管理的药学服务实践提供指引。 </P> <P> </P>拓展指南:<strong>与<font color=red>癌症</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=9d6da1c00183e90a" title="2019 ACOG委员会意见:遗传性癌症综合征和风险评估(No.793)" target=_blank>2019 ACOG委员会意见:遗传性癌症综合征和风险评估(No.793)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=01c631c00183e11a" title="2019 COSA立场声明:癌症生存者护理" target=_blank>2019 COSA立场声明:癌症生存者护理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=fb0d41c00180e7fb" title="《国际妇产科联盟(FIGO)2018癌症报告:子宫内膜癌诊治指南》解读" target=_blank>《国际妇产科联盟(FIGO)2018癌症报告:子宫内膜癌诊治指南》解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=72d5a1c001806886" title="NCCN临床实践指南:癌症相关疲劳(2019.V2)" target=_blank>NCCN临床实践指南:癌症相关疲劳(2019.V2)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=101ef1c001805669" title="2019 国际多学科圆桌会议共识声明:癌症幸存者运动指南" target=_blank>2019 国际多学科圆桌会议共识声明:癌症幸存者运动指南</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%99%8C%E7%97%87" target=_blank>有关癌症更多指南</a></ul>, tagList=[TagDto(tagId=97940, tagName=癌症疼痛管理)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4914, appHits=471, showAppHits=20, pcHits=2985, showPcHits=2459, likes=55, shares=20, comments=7, approvalStatus=1, publishedTime=Mon Dec 16 22:57:59 CST 2019, publishedTimeString=2019-11-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Dec 16 22:57:59 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 15:33:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=癌症疼痛管理药学专家共识)])
癌症疼痛管理药学专家共识
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=974402, encodeId=e2a59e4402bc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 15:12:29 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926463, encodeId=319a92646320, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcc72519873, createdName=124d8ef0m99暂无昵称, createdTime=Mon Feb 22 21:24:42 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920440, encodeId=4cd2920440de, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c8a5205736, createdName=1474bddbm72暂无昵称, createdTime=Wed Jan 27 22:04:25 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892816, encodeId=ee4f89281606, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/17516f06a53a4cf8b20993210840c5dd/8e57a4d799a845b9bc3fc17cb994a39c.jpg, createdBy=db415126199, createdName=146475c0m26(暂无昵称), createdTime=Sun Oct 18 11:42:23 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886766, encodeId=769f886e662d, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/5b0fca0db0bc45e4bbf5856776fdbac3/55b6fae4b2364aeeb492b1a4cf33dce0.jpg, createdBy=04ad5379290, createdName=ms1000001793617395, createdTime=Sun Sep 20 00:38:04 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2021-06-17 麻无赦

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=974402, encodeId=e2a59e4402bc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 15:12:29 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926463, encodeId=319a92646320, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcc72519873, createdName=124d8ef0m99暂无昵称, createdTime=Mon Feb 22 21:24:42 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920440, encodeId=4cd2920440de, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c8a5205736, createdName=1474bddbm72暂无昵称, createdTime=Wed Jan 27 22:04:25 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892816, encodeId=ee4f89281606, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/17516f06a53a4cf8b20993210840c5dd/8e57a4d799a845b9bc3fc17cb994a39c.jpg, createdBy=db415126199, createdName=146475c0m26(暂无昵称), createdTime=Sun Oct 18 11:42:23 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886766, encodeId=769f886e662d, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/5b0fca0db0bc45e4bbf5856776fdbac3/55b6fae4b2364aeeb492b1a4cf33dce0.jpg, createdBy=04ad5379290, createdName=ms1000001793617395, createdTime=Sun Sep 20 00:38:04 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2021-02-22 124d8ef0m99暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=974402, encodeId=e2a59e4402bc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 15:12:29 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926463, encodeId=319a92646320, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcc72519873, createdName=124d8ef0m99暂无昵称, createdTime=Mon Feb 22 21:24:42 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920440, encodeId=4cd2920440de, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c8a5205736, createdName=1474bddbm72暂无昵称, createdTime=Wed Jan 27 22:04:25 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892816, encodeId=ee4f89281606, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/17516f06a53a4cf8b20993210840c5dd/8e57a4d799a845b9bc3fc17cb994a39c.jpg, createdBy=db415126199, createdName=146475c0m26(暂无昵称), createdTime=Sun Oct 18 11:42:23 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886766, encodeId=769f886e662d, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/5b0fca0db0bc45e4bbf5856776fdbac3/55b6fae4b2364aeeb492b1a4cf33dce0.jpg, createdBy=04ad5379290, createdName=ms1000001793617395, createdTime=Sun Sep 20 00:38:04 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2021-01-27 1474bddbm72暂无昵称

    👍👍👍

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=974402, encodeId=e2a59e4402bc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 15:12:29 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926463, encodeId=319a92646320, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcc72519873, createdName=124d8ef0m99暂无昵称, createdTime=Mon Feb 22 21:24:42 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920440, encodeId=4cd2920440de, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c8a5205736, createdName=1474bddbm72暂无昵称, createdTime=Wed Jan 27 22:04:25 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892816, encodeId=ee4f89281606, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/17516f06a53a4cf8b20993210840c5dd/8e57a4d799a845b9bc3fc17cb994a39c.jpg, createdBy=db415126199, createdName=146475c0m26(暂无昵称), createdTime=Sun Oct 18 11:42:23 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886766, encodeId=769f886e662d, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/5b0fca0db0bc45e4bbf5856776fdbac3/55b6fae4b2364aeeb492b1a4cf33dce0.jpg, createdBy=04ad5379290, createdName=ms1000001793617395, createdTime=Sun Sep 20 00:38:04 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2020-10-18 146475c0m26(暂无昵称)

    学习了。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=974402, encodeId=e2a59e4402bc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/0922a5df24904e4f86d563d49079aa1d/bf4a0e7be5fb4e7892ff94a8306fe9b7.jpg, createdBy=fc9b4705948, createdName=麻无赦, createdTime=Thu Jun 17 15:12:29 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926463, encodeId=319a92646320, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcc72519873, createdName=124d8ef0m99暂无昵称, createdTime=Mon Feb 22 21:24:42 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920440, encodeId=4cd2920440de, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c8a5205736, createdName=1474bddbm72暂无昵称, createdTime=Wed Jan 27 22:04:25 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892816, encodeId=ee4f89281606, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/17516f06a53a4cf8b20993210840c5dd/8e57a4d799a845b9bc3fc17cb994a39c.jpg, createdBy=db415126199, createdName=146475c0m26(暂无昵称), createdTime=Sun Oct 18 11:42:23 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886766, encodeId=769f886e662d, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/5b0fca0db0bc45e4bbf5856776fdbac3/55b6fae4b2364aeeb492b1a4cf33dce0.jpg, createdBy=04ad5379290, createdName=ms1000001793617395, createdTime=Sun Sep 20 00:38:04 CST 2020, time=2020-09-20, status=1, ipAttribution=)]
    2020-09-20 ms1000001793617395

    👍

    0